Molina Healthcare (MOH) Earns In-Line Rating from Analysts at Evercore ISI
Evercore ISI assumed coverage on shares of Molina Healthcare (NYSE:MOH) in a research report report published on Tuesday morning, Marketbeat reports. The firm issued an in-line rating and a $158.00 target price on the stock.
Several other equities research analysts have also commented on MOH. BMO Capital Markets upped their price target on Molina Healthcare to $105.00 and gave the stock a market perform rating in a research note on Tuesday, June 19th. Jefferies Financial Group upgraded Molina Healthcare from a hold rating to a buy rating and set a $74.00 price target for the company in a research note on Friday, June 22nd. JPMorgan Chase & Co. lowered Molina Healthcare from an overweight rating to a neutral rating in a research note on Wednesday, June 27th. They noted that the move was a valuation call. Wells Fargo & Co upped their price target on Molina Healthcare from $90.00 to $92.00 and gave the stock a market perform rating in a research note on Thursday, June 28th. Finally, Zacks Investment Research upgraded Molina Healthcare from a hold rating to a strong-buy rating and set a $113.00 price target for the company in a research note on Saturday, June 30th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and six have issued a buy rating to the company’s stock. The stock presently has an average rating of Hold and a consensus price target of $129.31.
Molina Healthcare stock opened at $139.54 on Tuesday. The firm has a market capitalization of $9.18 billion, a P/E ratio of 249.18, a price-to-earnings-growth ratio of 1.45 and a beta of 1.26. Molina Healthcare has a 52 week low of $58.66 and a 52 week high of $154.06. The company has a quick ratio of 1.38, a current ratio of 1.38 and a debt-to-equity ratio of 0.73.
In other news, Director Daniel Cooperman sold 943 shares of the stock in a transaction dated Tuesday, August 14th. The stock was sold at an average price of $133.81, for a total value of $126,182.83. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Norman Nichols sold 4,501 shares of the stock in a transaction dated Wednesday, August 8th. The shares were sold at an average price of $127.00, for a total value of $571,627.00. The disclosure for this sale can be found here. Insiders have sold 9,717 shares of company stock valued at $1,289,932 over the last 90 days. 0.65% of the stock is currently owned by insiders.
Several hedge funds have recently bought and sold shares of MOH. Advisors Asset Management Inc. boosted its holdings in Molina Healthcare by 2,264.2% in the second quarter. Advisors Asset Management Inc. now owns 93,813 shares of the company’s stock valued at $118,000 after purchasing an additional 89,845 shares during the last quarter. Integrated Investment Consultants LLC purchased a new position in Molina Healthcare in the second quarter valued at about $165,000. Contravisory Investment Management Inc. purchased a new position in Molina Healthcare in the second quarter valued at about $166,000. Zeke Capital Advisors LLC purchased a new position in Molina Healthcare in the second quarter valued at about $206,000. Finally, CIBC Asset Management Inc purchased a new position in Molina Healthcare in the second quarter valued at about $211,000.
About Molina Healthcare
Molina Healthcare, Inc provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program in the United States. It operates through three segments: Health Plans, Molina Medicaid Solutions, and Other.
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.